Your password has been changed successfully.
|Please click here to Login with the new Password.|
According to UPI, The U.S. Food and Drug Administration has released a series of technical guides to assist developers in the creation of generic versions of complex drugs that are applied to a patient's skin. Transdermal and topical delivery systems, known as TDS, necessitate exact medication doses to be delivered consistently and for a very specific amount of time. The FDA has issued 25 product-specific guides that will support the generic drug industry in identifying appropriate methodologies and evidence for developing the generic TDS products.